Publikationer i DiVA – Gunilla Enblad
-
A whole-body diffusion MRI normal atlas: development, evaluation and initial use
Ingår i Cancer Imaging, 2023.
DOI för A whole-body diffusion MRI normal atlas: development, evaluation and initial use Ladda ner fulltext (pdf) av A whole-body diffusion MRI normal atlas: development, evaluation and initial use
-
Next generation pan-cancer blood proteome profiling using proximity extension assay
Ingår i Nature Communications, 2023.
DOI för Next generation pan-cancer blood proteome profiling using proximity extension assay Ladda ner fulltext (pdf) av Next generation pan-cancer blood proteome profiling using proximity extension assay
-
Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects
Ingår i Cancers, 2023.
DOI för Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects Ladda ner fulltext (pdf) av Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects
-
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
Ingår i HemaSphere, 2023.
DOI för Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden Ladda ner fulltext (pdf) av Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
-
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
Ingår i Journal of Clinical Investigation, 2023.
DOI för Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma Ladda ner fulltext (pdf) av Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
-
Advances in immune therapies in hematological malignancies
Ingår i Journal of Internal Medicine, s. 205-220, 2022.
DOI för Advances in immune therapies in hematological malignancies Ladda ner fulltext (pdf) av Advances in immune therapies in hematological malignancies
-
Checkpoint CD47 expression in classical Hodgkin lymphoma
Ingår i British Journal of Haematology, s. 580-589, 2022.
DOI för Checkpoint CD47 expression in classical Hodgkin lymphoma Ladda ner fulltext (pdf) av Checkpoint CD47 expression in classical Hodgkin lymphoma
-
COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients
Ingår i Pediatric Blood & Cancer, 2022.
DOI för COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients Ladda ner fulltext (pdf) av COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients
-
Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
Ingår i PLOS ONE, 2022.
DOI för Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis Ladda ner fulltext (pdf) av Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
-
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
Ingår i Journal of Clinical Oncology, s. 1487-1496, 2022.
DOI för Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy Ladda ner fulltext (pdf) av Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
-
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2022.
DOI för Noninvasive detection of any-stage cancer using free glycosaminoglycans Ladda ner fulltext (pdf) av Noninvasive detection of any-stage cancer using free glycosaminoglycans
-
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Ingår i British Journal of Haematology, s. 267-277, 2022.
DOI för Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients Ladda ner fulltext (pdf) av Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
-
Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
Ingår i International Journal of Cancer, s. 773-781, 2022.
DOI för Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes Ladda ner fulltext (pdf) av Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
-
Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
Ingår i New Biotechnology, s. 21-29, 2022.
DOI för Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls Ladda ner fulltext (pdf) av Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
-
The dual role of CD70 in B‐cell lymphomagenesis
Ingår i Clinical and Translational Medicine, 2022.
DOI för The dual role of CD70 in B‐cell lymphomagenesis Ladda ner fulltext (pdf) av The dual role of CD70 in B‐cell lymphomagenesis
-
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
Ingår i Genes, Chromosomes and Cancer, s. 27-36, 2022.
DOI för Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology Ladda ner fulltext (pdf) av Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
-
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
Ingår i Cancer Imaging, 2022.
DOI för Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy Ladda ner fulltext (pdf) av Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
-
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
Ingår i British Journal of Haematology, s. 906-914, 2021.
DOI för Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study Ladda ner fulltext (pdf) av Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
-
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
Ingår i Cancer Immunology and Immunotherapy, s. 2851-2865, 2021.
DOI för Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy Ladda ner fulltext (pdf) av Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
-
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
Ingår i Acta Oncologica, s. 1459-1465, 2021.
DOI för Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study Ladda ner fulltext (pdf) av Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
-
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Ingår i Upsala Journal of Medical Sciences, 2021.
DOI för High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors? Ladda ner fulltext (pdf) av High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
-
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Ingår i Blood Cancer Journal, 2021.
DOI för Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden Ladda ner fulltext (pdf) av Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
-
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
Ingår i Acta Oncologica, s. 531-538, 2021.
DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
-
Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
Ingår i Cardio-Oncology, 2021.
DOI för Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma Ladda ner fulltext (pdf) av Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
-
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
Ingår i Acta Oncologica, s. 771-778, 2021.
DOI för Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders Ladda ner fulltext (pdf) av Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
-
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Ingår i Haematologica, s. 2502-2506, 2021.
DOI för Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma Ladda ner fulltext (pdf) av Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
-
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Ingår i Blood Advances, s. 1671-1681, 2021.
DOI för Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
-
Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
Ingår i Upsala Journal of Medical Sciences, 2021.
DOI för Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma Ladda ner fulltext (pdf) av Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
-
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
Ingår i British Journal of Haematology, s. 568-579, 2021.
DOI för Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden Ladda ner fulltext (pdf) av Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
-
CD30 expression and survival in posttransplant lymphoproliferative disorders
Ingår i Acta Oncologica, s. 673-680, 2020.
DOI för CD30 expression and survival in posttransplant lymphoproliferative disorders Ladda ner fulltext (pdf) av CD30 expression and survival in posttransplant lymphoproliferative disorders
-
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
Ingår i American Journal of Hematology, s. E287-E289, 2020.
DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
-
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
Ingår i British Journal of Haematology, s. 685-691, 2020.
-
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Ingår i American Journal of Hematology, s. 740-748, 2020.
DOI för Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma Ladda ner fulltext (pdf) av Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
-
Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
Ingår i Immunobiology, 2020.
DOI för Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma Ladda ner fulltext (pdf) av Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
-
Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
Ingår i European Journal of Haematology, s. 207-213, 2020.
DOI för Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma Ladda ner fulltext (pdf) av Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
-
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Ingår i Transplant International, s. 1700-1710, 2020.
DOI för Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study Ladda ner fulltext (pdf) av Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
-
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Ingår i Trials, 2020.
DOI för The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer Ladda ner fulltext (pdf) av The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
-
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
Ingår i BMC Cancer, 2020.
DOI för Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib Ladda ner fulltext (pdf) av Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
-
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
Ingår i BMC Cancer, 2019.
DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
-
Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
Ingår i Leukemia and Lymphoma, s. 376-384, 2019.
DOI för Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
-
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy
Ingår i British Journal of Haematology, s. 431-439, 2019.
-
High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms
Ingår i British Journal of Haematology, s. 192-201, 2019.
-
Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
Ingår i Journal of Cancer, s. 3224-3231, 2019.
DOI för Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib Ladda ner fulltext (pdf) av Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
-
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
Ingår i Clinical Cancer Research, s. 6185-6194, 2018.
-
An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
Ingår i European Journal of Haematology, s. 88-97, 2018.
DOI för An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome Ladda ner fulltext (pdf) av An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
-
Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
Ingår i Annals of Hematology, s. 2129-2135, 2018.
DOI för Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome? Ladda ner fulltext (pdf) av Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
-
Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
Ingår i PLOS ONE, 2018.
DOI för Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma Ladda ner fulltext (pdf) av Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
-
Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients
Ingår i British Journal of Haematology, s. 770-781, 2018.
-
Imiomics Using Whole-body FDG PET/MR in Staging and Treatment Response Evaluation of Non-Hodgkin Lymphoma Patients Treated With CAR-T Cells
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. S37-S38, 2018.
-
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ingår i American Journal of Hematology, s. 1020-1028, 2018.
-
Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study
Ingår i Annals of Oncology, s. 1882-1883, 2018.
-
U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
Ingår i Acta Oncologica, s. 187-194, 2018.
DOI för U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. Ladda ner fulltext (pdf) av U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
-
Does the omission of vincristine affect outcome and survival in patients with diffuse large B-cell lymphoma?
Ingår i Annals of Oncology, 2017.
-
Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation
Ingår i American Journal of Transplantation, s. 472-472, 2017.
DOI för Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation
-
Estrogen receptor beta 1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker
Ingår i Leukemia and Lymphoma, s. 418-427, 2017.
-
Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma
Ingår i European Journal of Haematology, s. 52-56, 2017.
-
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Ingår i Blood Advances, s. 1427-1439, 2017.
-
Immunological biomarkers correlate to survival in CAR19-treated patients
Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017.
-
Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.
Ingår i Acta Dermato-Venereologica, s. 751-753, 2017.
-
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
Ingår i Journal of Cancer, s. 3975-3983, 2017.
DOI för Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients Ladda ner fulltext (pdf) av Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
-
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
Ingår i Journal of Cancer Research and Clinical Oncology, s. 961-970, 2017.
DOI för Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib Ladda ner fulltext (pdf) av Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
-
A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia
Ingår i Molecular Therapy, s. S295-S296, 2016.
-
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Ingår i New England Journal of Medicine, s. 2419-2429, 2016.
DOI för Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
-
CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial
Ingår i CANCER IMMUNOLOGY RESEARCH, 2016.
-
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Ingår i British Journal of Haematology, s. 614-622, 2016.
-
Prognostic Implications Of An Active, Innate Or Anergic Immune Response In The Hodgkin Lymphoma Tumor Microenvironment
Ingår i Haematologica, s. 3-3, 2016.
-
The Importance Of Bone Marrow 18F-Fdg Uptake And Focal Skeletal Lesions On Survival In Patients With Newly Diagnosed Hodgkin Lymphoma
Ingår i Haematologica, s. 42-42, 2016.
-
The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
Ingår i European Journal of Haematology, s. 430-438, 2016.
DOI för The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children Ladda ner fulltext (pdf) av The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children
-
CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma
Ingår i Human Gene Therapy, s. 498-505, 2015.
DOI för CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma
-
Elevated Post-Transplant Cancer Incidence And Reduced Survival In Patients With Pretransplant Tumors
Ingår i Transplant International, s. 183-184, 2015.
-
Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders: Clinical Features and Survival Outcomes
Ingår i Transplantation, s. 1036-1042, 2015.
-
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Ingår i Journal of Experimental Medicine, s. 833-843, 2015.
DOI för Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia Ladda ner fulltext (pdf) av Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
-
Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma - a Swedish population-based study
Ingår i Acta Oncologica, s. 924-932, 2015.
-
Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation
Ingår i American Journal of Transplantation, s. 2838-2845, 2014.